Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

BACKGROUND: In patients with chronic infection with hepatitis C virus (HCV) genotype 1 who do not have a sustained response to therapy with peginterferon–ribavirin, outcomes after retreatment are suboptimal. Boceprevir, a protease inhibitor that binds to the HCV nonstructural 3 (NS3) active site, ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bacon, Bruce R., Gordon, Stuart C., Lawitz, Eric, Marcellin, Patrick, Vierling, John M., Zeuzem, Stefan, Poordad, Fred, Goodman, Zachary D., Sings, Heather L., Boparai, Navdeep, Burroughs, Margaret, Brass, Clifford A., Albrecht, Janice K., Esteban, Rafael
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3153125/
https://ncbi.nlm.nih.gov/pubmed/21449784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1009482
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados